Location History:
- Frakfurt am Main-Fechenheim, DE (1976)
- Frankfurt-am-Main, DE (1976 - 1978)
Company Filing History:
Years Active: 1976-1978
Title: Klaus Resag: Innovator in Pharmaceutical Chemistry
Introduction: Klaus Resag is a notable inventor based in Frankfurt-am-Main, Germany, recognized for his significant contributions to pharmaceutical chemistry, particularly in the development of benzophenone and coumarin derivatives. With a total of five patents, Resag's work showcases innovative approaches to pharmacologically valuable compounds.
Latest Patents: Among his latest inventions, Resag has developed benzophenone derivatives that exhibit pronounced sedative effects on the central nervous system while showcasing additional muscle-relaxing and aggression-inhibiting properties. These compounds feature specific structural formulas and are manufactured through detailed chemical reactions involving various substituents and conditions. Additionally, Resag’s patent portfolio includes piperazino substituted coumarin derivatives, which serve as coronary dilators and are synthesized using particular acylating and condensing methods, showcasing a wide array of useful applications in medicine.
Career Highlights: Resag has made remarkable strides in the pharmaceutical field, primarily focusing on the synthesis and development of innovative compounds that address critical health issues. His tenure at Cassella Farbwerke Mainkur Aktiengesellschaft has been instrumental in furthering his research and applications in pharmacology.
Collaborations: Throughout his career, Klaus collaborates with fellow researchers, including Heinz Gunter Greve and Rudi Beyerle, which has fostered an environment of innovation and shared expertise within the realm of pharmaceutical development.
Conclusion: Klaus Resag stands as an influential figure in the world of invention, particularly in the pharmaceutical sector, with five patents reflecting his deep understanding of chemistry and its application to health sciences. His continued research and collaborative efforts signify his commitment to advancing medical science through innovative solutions.